nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical outcomes linked to expression of gene subsets for protein hormones and their cognate receptors from LCM-procured breast carcinoma cells
|
Daniels, Michael W. |
|
2016 |
161 |
2 |
p. 245-258 |
artikel |
2 |
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan
|
Rashid, Muhammad U. |
|
2016 |
161 |
2 |
p. 191-201 |
artikel |
3 |
Differences in mammographic density between Asian and Caucasian populations: a comparative analysis
|
Rajaram, Nadia |
|
2016 |
161 |
2 |
p. 353-362 |
artikel |
4 |
Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample
|
Griggs, Jennifer J. |
|
2016 |
161 |
2 |
p. 375-384 |
artikel |
5 |
Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals
|
Huang, J. |
|
2016 |
161 |
2 |
p. 229-243 |
artikel |
6 |
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience
|
Bourke, Mike G. |
|
2016 |
161 |
2 |
p. 289-297 |
artikel |
7 |
Endocan as a prognostic biomarker of triple-negative breast cancer
|
Sagara, Atsunobu |
|
2016 |
161 |
2 |
p. 269-278 |
artikel |
8 |
Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
|
Elshof, Lotte E. |
|
2016 |
161 |
2 |
p. 389-390 |
artikel |
9 |
Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial
|
Zick, Suzanna Maria |
|
2016 |
161 |
2 |
p. 299-310 |
artikel |
10 |
First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer
|
Altundag, Kadri |
|
2016 |
161 |
2 |
p. 385 |
artikel |
11 |
In reply to Kadri Altundag
|
Cazzaniga, Marina E. |
|
2016 |
161 |
2 |
p. 387 |
artikel |
12 |
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
|
Chlebowski, Rowan T. |
|
2016 |
161 |
2 |
p. 185-190 |
artikel |
13 |
Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study
|
Connor, Avonne E. |
|
2016 |
161 |
2 |
p. 321-331 |
artikel |
14 |
Previous GWAS hits in relation to young-onset breast cancer
|
Shi, Min |
|
2016 |
161 |
2 |
p. 333-344 |
artikel |
15 |
Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)
|
Freedman, Rachel A. |
|
2016 |
161 |
2 |
p. 363-373 |
artikel |
16 |
The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer
|
McNamara, Keely May |
|
2016 |
161 |
2 |
p. 213-227 |
artikel |
17 |
Trends in cardiac mortality in women with ductal carcinoma in situ
|
Haque, Waqar |
|
2016 |
161 |
2 |
p. 345-351 |
artikel |
18 |
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
|
Li, Xiaoxian |
|
2016 |
161 |
2 |
p. 279-287 |
artikel |
19 |
Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study
|
Masala, Giovanna |
|
2016 |
161 |
2 |
p. 311-320 |
artikel |
20 |
Using machine learning to parse breast pathology reports
|
Yala, Adam |
|
2016 |
161 |
2 |
p. 203-211 |
artikel |
21 |
Weekly paclitaxel plus carboplatin with or without trastuzumab as neoadjuvant chemotherapy for HER2-positive breast cancer: loss of HER2 amplification and its impact on response and prognosis
|
Wang, Ruo-Xi |
|
2016 |
161 |
2 |
p. 259-267 |
artikel |